GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Healthy Extracts Inc (OTCPK:HYEX) » Definitions » Cyclically Adjusted Price-to-FCF

HYEX (Healthy Extracts) Cyclically Adjusted Price-to-FCF : (As of May. 25, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Healthy Extracts Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Healthy Extracts Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Healthy Extracts's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healthy Extracts Cyclically Adjusted Price-to-FCF Chart

Healthy Extracts Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Healthy Extracts Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Healthy Extracts's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Healthy Extracts's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healthy Extracts's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Healthy Extracts's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Healthy Extracts's Cyclically Adjusted Price-to-FCF falls into.


;
;

Healthy Extracts Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Healthy Extracts's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Healthy Extracts's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.02/134.9266*134.9266
=0.020

Current CPI (Mar. 2025) = 134.9266.

Healthy Extracts Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.000 100.684 0.000
201509 0.000 100.392 0.000
201512 0.000 99.792 0.000
201603 -105.000 100.470 -141.010
201606 -73.000 101.688 -96.861
201609 -168.000 101.861 -222.535
201612 -194.000 101.863 -256.971
201703 -225.000 102.862 -295.137
201706 -130.000 103.349 -169.720
201709 -63.000 104.136 -81.628
201712 -36.286 104.011 -47.071
201803 -15.667 105.290 -20.077
201806 -7.125 106.317 -9.042
201809 -1.375 106.507 -1.742
201812 -0.093 105.998 -0.118
201903 -3.447 107.251 -4.337
201906 0.000 108.070 0.000
201909 -0.891 108.329 -1.110
201912 1.339 108.420 1.666
202003 -0.173 108.902 -0.214
202006 -1.096 108.767 -1.360
202009 -0.585 109.815 -0.719
202012 0.498 109.897 0.611
202103 -0.258 111.754 -0.311
202106 -0.027 114.631 -0.032
202109 -0.108 115.734 -0.126
202112 0.011 117.630 0.013
202203 -0.044 121.301 -0.049
202206 -0.017 125.017 -0.018
202209 -0.030 125.227 -0.032
202212 -0.052 125.222 -0.056
202303 -0.120 127.348 -0.127
202306 -0.021 128.729 -0.022
202309 -0.023 129.860 -0.024
202312 0.019 129.419 0.020
202403 0.007 131.776 0.007
202406 0.057 132.554 0.058
202409 0.017 133.029 0.017
202412 0.014 133.157 0.014
202503 0.020 134.927 0.020

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Healthy Extracts  (OTCPK:HYEX) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Healthy Extracts Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Healthy Extracts's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Healthy Extracts Business Description

Traded in Other Exchanges
N/A
Address
7375 Commercial Way, Suite 125, Henderson, NV, USA, 89011
Healthy Extracts Inc through its subsidiaries is engaged in proprietary research and development of natural plant-based formulations, manufacturing, sales, and distribution of cardiovascular and neuro products that provide natural brain solutions. The company also provides superfruit supplements to support overall cholesterol and cardiovascular health. Its products are distributed in the United States and Mexico. Its operating segment includes, Health Supplements and Corporate. The company generates maximum revenue from the Health Supplements segment.
Executives
Robert Michael Madden officer: Chief Financial Officer 5269 SOUTH ALVERA CIR, SALT LAKE CITY UT 84117
Croyle William Russell Jr director 1 SILVERMOUND, LITTLETON CO 80127
Kevin Pitts 10 percent owner, officer: President 3664 CHRISTY RIDGE RD., SEDALIA CO 80135
Sanjeevkumar Ratanshi Javia director, officer: President 7161 E. RANCHO VISTA DRIVE, SUITE 3008, SCOTTSDALE AZ 85251
Patrick Stiles director, 10 percent owner, officer: President, CEO 10300 W. CHARLESTON, LAS VEGAS NV 89135
Joseph Nejman director, 10 percent owner, officer: President 555 BRYANT ST., SUITE 555, PALO ALTO CA 94301
William C Bossung director, 10 percent owner, officer: CFO and Secretary 10300 W. CHARLESTON BLVD., STE. 13-378, LAS VEGAS NV 89135
Brian J Dunn director, 10 percent owner 7075 FLYING CLOUD DRIVE, EDEN PRAIRIE MN 55344
Fred Covely director, 10 percent owner, officer: President and CEO 1508 GRANDVIEW RD., VISTA CA 92084